Higher expression level of CSC markers including ALDH1A1, CD44, and CD133 was also reported in tumor tissues collected immediately after primary chemotherapy compared with paired primary samples from EOC patients [17]. This evidence concerns the gene ALDH1A1 and neoplasm.